These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

200 related articles for article (PubMed ID: 24113455)

  • 1. Hepatic loss of miR-122 predisposes mice to hepatobiliary cyst and hepatocellular carcinoma upon diethylnitrosamine exposure.
    Hsu SH; Wang B; Kutay H; Bid H; Shreve J; Zhang X; Costinean S; Bratasz A; Houghton P; Ghoshal K
    Am J Pathol; 2013 Dec; 183(6):1719-1730. PubMed ID: 24113455
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Persistent mTORC1 activation via Depdc5 deletion results in spontaneous hepatocellular carcinoma but does not exacerbate carcinogen- and high-fat diet-induced hepatic carcinogenesis in mice.
    Xu L; Yang C; Wang J; Li Z; Huang R; Ma H; Ma J; Wang Q; Xiong X
    Biochem Biophys Res Commun; 2021 Nov; 578():142-149. PubMed ID: 34562654
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Tumor-Extrinsic Axl Expression Shapes an Inflammatory Microenvironment Independent of Tumor Cell Promoting Axl Signaling in Hepatocellular Carcinoma.
    Breitenecker K; Heiden D; Demmer T; Weber G; Primorac AM; Hedrich V; Ortmayr G; Gruenberger T; Starlinger P; Herndler-Brandstetter D; Barozzi I; Mikulits W
    Int J Mol Sci; 2024 Apr; 25(8):. PubMed ID: 38673795
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Constitutive Notch2 signaling induces hepatic tumors in mice.
    Dill MT; Tornillo L; Fritzius T; Terracciano L; Semela D; Bettler B; Heim MH; Tchorz JS
    Hepatology; 2013 Apr; 57(4):1607-19. PubMed ID: 23175466
    [TBL] [Abstract][Full Text] [Related]  

  • 5. TREM-2 defends the liver against hepatocellular carcinoma through multifactorial protective mechanisms.
    Esparza-Baquer A; Labiano I; Sharif O; Agirre-Lizaso A; Oakley F; Rodrigues PM; Zhuravleva E; O'Rourke CJ; Hijona E; Jimenez-Agüero R; Riaño I; Landa A; La Casta A; Zaki MYW; Munoz-Garrido P; Azkargorta M; Elortza F; Vogel A; Schabbauer G; Aspichueta P; Andersen JB; Knapp S; Mann DA; Bujanda L; Banales JM; Perugorria MJ
    Gut; 2021 Jul; 70(7):1345-1361. PubMed ID: 32907830
    [TBL] [Abstract][Full Text] [Related]  

  • 6. GSTZ1 deficiency promotes hepatocellular carcinoma proliferation via activation of the KEAP1/NRF2 pathway.
    Li J; Wang Q; Yang Y; Lei C; Yang F; Liang L; Chen C; Xia J; Wang K; Tang N
    J Exp Clin Cancer Res; 2019 Oct; 38(1):438. PubMed ID: 31666108
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Role of insulin receptor substrates in the progression of hepatocellular carcinoma.
    Sakurai Y; Kubota N; Takamoto I; Obata A; Iwamoto M; Hayashi T; Aihara M; Kubota T; Nishihara H; Kadowaki T
    Sci Rep; 2017 Jul; 7(1):5387. PubMed ID: 28710407
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Deletion of IFNγ enhances hepatocarcinogenesis in FXR knockout mice.
    Meng Z; Wang X; Gan Y; Zhang Y; Zhou H; Ness CV; Wu J; Lou G; Yu H; He C; Xu R; Huang W
    J Hepatol; 2012 Nov; 57(5):1004-12. PubMed ID: 22728874
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pregnane X receptor (PXR) deficiency promotes hepatocarcinogenesis via induction of Akr1c18 expression and prostaglandin F
    Shi T; Fan QY; Liu SB; Zhang SY
    Biochem Pharmacol; 2024 Jul; 225():116309. PubMed ID: 38788959
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Multigenerational maternal obesity increases the incidence of HCC in offspring via miR-27a-3p.
    Sun Y; Wang Q; Zhang Y; Geng M; Wei Y; Liu Y; Liu S; Petersen RB; Yue J; Huang K; Zheng L
    J Hepatol; 2020 Sep; 73(3):603-615. PubMed ID: 32593682
    [TBL] [Abstract][Full Text] [Related]  

  • 11. BOK promotes chemical-induced hepatocarcinogenesis in mice.
    Rabachini T; Fernandez-Marrero Y; Montani M; Loforese G; Sladky V; He Z; Bachmann D; Wicki S; Villunger A; Stroka D; Kaufmann T
    Cell Death Differ; 2018 Mar; 25(4):708-720. PubMed ID: 29229991
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Intravenous miR-144 inhibits tumor growth in diethylnitrosamine-induced hepatocellular carcinoma in mice.
    He Q; Wang F; Honda T; Lindquist DM; Dillman JR; Timchenko NA; Redington AN
    Tumour Biol; 2017 Oct; 39(10):1010428317737729. PubMed ID: 29072132
    [TBL] [Abstract][Full Text] [Related]  

  • 13. NADPH Oxidase 1 in Liver Macrophages Promotes Inflammation and Tumor Development in Mice.
    Liang S; Ma HY; Zhong Z; Dhar D; Liu X; Xu J; Koyama Y; Nishio T; Karin D; Karin G; Mccubbin R; Zhang C; Hu R; Yang G; Chen L; Ganguly S; Lan T; Karin M; Kisseleva T; Brenner DA
    Gastroenterology; 2019 Mar; 156(4):1156-1172.e6. PubMed ID: 30445007
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Conditional beta-catenin loss in mice promotes chemical hepatocarcinogenesis: role of oxidative stress and platelet-derived growth factor receptor alpha/phosphoinositide 3-kinase signaling.
    Zhang XF; Tan X; Zeng G; Misse A; Singh S; Kim Y; Klaunig JE; Monga SP
    Hepatology; 2010 Sep; 52(3):954-65. PubMed ID: 20583210
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Timp3 deficiency affects the progression of DEN-related hepatocellular carcinoma during diet-induced obesity in mice.
    Casagrande V; Mauriello A; Anemona L; Mavilio M; Iuliani G; De Angelis L; D'Onofrio M; Arisi I; Federici M; Menghini R
    Acta Diabetol; 2019 Dec; 56(12):1265-1274. PubMed ID: 31292722
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Bile acids promote diethylnitrosamine-induced hepatocellular carcinoma via increased inflammatory signaling.
    Sun L; Beggs K; Borude P; Edwards G; Bhushan B; Walesky C; Roy N; Manley MW; Gunewardena S; O'Neil M; Li H; Apte U
    Am J Physiol Gastrointest Liver Physiol; 2016 Jul; 311(1):G91-G104. PubMed ID: 27151938
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Spectrum of molecular changes during hepatocarcinogenesis induced by DEN and other chemicals in Fischer 344 male rats.
    Lim IK
    Mech Ageing Dev; 2002 Nov; 123(12):1665-80. PubMed ID: 12470904
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Romidepsin hepatocellular carcinoma suppression in mice is associated with deregulated gene expression of bone morphogenetic protein and Notch signaling pathway components.
    Afaloniati H; Poutahidis T; Giakoustidis A; Gargavanis A; Giakoustidis D; Angelopoulou K
    Mol Biol Rep; 2021 Jan; 48(1):551-562. PubMed ID: 33393006
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Loss of immunity-supported senescence enhances susceptibility to hepatocellular carcinogenesis and progression in Toll-like receptor 2-deficient mice.
    Lin H; Yan J; Wang Z; Hua F; Yu J; Sun W; Li K; Liu H; Yang H; Lv Q; Xue J; Hu ZW
    Hepatology; 2013 Jan; 57(1):171-82. PubMed ID: 22859216
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Induction of p53 renders ATM-deficient mice refractory to hepatocarcinogenesis.
    Teoh N; Pyakurel P; Dan YY; Swisshelm K; Hou J; Mitchell C; Fausto N; Gu Y; Farrell G
    Gastroenterology; 2010 Mar; 138(3):1155-65.e1-2. PubMed ID: 19919837
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.